Ipsen
Maria Fitzgerald is a seasoned professional in the field of drug metabolism and pharmacokinetics (DMPK), currently serving as Senior Director and Head of DMPK at Ipsen since January 2023. With a robust background, Maria has previously held senior leadership positions at Epizyme, where responsibilities included overseeing DMPK for oncology projects, and at Sanofi, where Maria led various functional groups and contributed significantly to IND submissions and global assay harmonization efforts. Prior experience at Genzyme involved managing the In Vitro ADME Group, focusing on drug discovery and development. Maria holds educational qualifications from Boston College and Le Moyne College.
This person is not in the org chart
This person is not in any offices
Ipsen
22 followers
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease.